Involvement of Immune Cell Network in Aortic Valve Stenosis: Communication between Valvular Interstitial Cells and Immune Cells
1
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Aortic valve stenosis is a heart disease prevalent in the elderly characterized by valvular calcification, fibrosis, and inflammation, but its exact pathogenesis remains unclear. Previously, aortic valve stenosis was thought to be caused by chronic passive and degenerative changes associated with aging. However, recent studies have demonstrated that atherosclerotic processes and inflammation can induce valvular calcification and bone deposition, leading to valvular stenosis. In particular, the most abundant cell type in cardiac valves, valvular interstitial cells, can differentiate into myofibroblasts and osteoblast-like cells, leading to valvular calcification and stenosis. Differentiation of valvular interstitial cells can be trigged by inflammatory stimuli from several immune cell types, including macrophages, dendritic cells, T cells, B cells, and mast cells. This review indicates that crosstalk between immune cells and valvular interstitial cells plays an important role in the development of aortic valve stenosis.
Abstract
Aortic valve stenosis is a heart disease prevalent in the elderly characterized by valvular calcification, fibrosis, and inflammation, but its exact pathogenesis remains unclear. Previously, aortic valve stenosis was thought to be caused by chronic passive and degenerative changes associated with aging. However, recent studies have demonstrated that atherosclerotic processes and inflammation can induce valvular calcification and bone deposition, leading to valvular stenosis. In particular, the most abundant cell type in cardiac valves, valvular interstitial cells, can differentiate into myofibroblasts and osteoblast-like cells, leading to valvular calcification and stenosis. Differentiation of valvular interstitial cells can be trigged by inflammatory stimuli from several immune cell types, including macrophages, dendritic cells, T cells, B cells, and mast cells. This review indicates that crosstalk between immune cells and valvular interstitial cells plays an important role in the development of aortic valve stenosis.
참고문헌 (63)
- Dweck, M. R., "Calcific aortic stenosis: a disease of the valve and the myocardium", J. Am. Coll. Cardiol, 60, pp.1854~1863 (2012)
- Towler, D. A., "Molecular and cellular aspects of calcific aortic valve disease", Circ. Res, 113, pp.198~208 (2013)
- Nkomo, V. T., "Burden of valvular heart diseases: a population-based study", Lancet, 368, pp.1005~1011 (2006)
- Otto, C. M., "Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly", N. Engl. J. Med, 341, pp.142~147 (1999)
- Otto, C. M., "Timing of aortic valve surgery", Heart, 84, pp.211~218 (2000)
- Moura, L. M., "Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis", J. Am. Coll. Cardiol, 49, pp.554~561 (2007)
- Rosenhek, R., "Statins but not angiotensin-converting enzyme inhibitors delay progression of aortic stenosis", Circulation, 110, pp.1291~1295 (2004)
- Cowell, S. J., "A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis", N. Engl. J. Med, 352, pp.2389~2397 (2005)
- Rossebo, A. B., "Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis", N. Engl. J. Med, 359, pp.1343~1356 (2008)
- Aikawa, E., "Look more closely at the valve:imaging calcific aortic valve disease", Circulation, 125, pp.9~11 (2012)
- New, S. E., "Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification", Circ. Res, 108, pp.1381~1391 (2011)
- Combs, M. D., "Heart valve development:regulatory networks in development and disease", Circ. Res, 105, pp.408~421 (2009)
- Wang, H., "Cardiac valve cells and their microenvironment--insights from in vitro studies", Nat. Rev. Cardiol, 11, pp.715~727 (2014)
- Liu, A. C., "The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology", Am. J. Pathol, 171, pp.1407~1418 (2007)
- Rajamannan, N. M., "Calcific aortic valve disease:not simply a degenerative process: A review and agenda for research from the National Heart and Lung and Blood Institute Aortic Stenosis Working Group. Executive summary: Calcific aortic valve disease-2011 update", Circulation, 124, pp.1783~1791 (2011)
- Jian, B., "Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis", Ann. Thorac. Surg, 75, pp.457~465 (2003)
- Li, C., "Transforming growth factor-beta regulates the growth of valve interstitial cells in vitro", Am. J. Pathol, 179, pp.1746~1755 (2011)
- Osman, L., "Role of human valve interstitial cells in valve calcification and their response to atorvastatin", Circulation, 114, pp.I547~I552 (2006)
- Hinz, B., "Formation and function of the myofibroblast during tissue repair", J. Invest. Dermatol, 127, pp.526~537 (2007)
- Rajamannan, N. M., "Human aortic valve calcification is associated with an osteoblast phenotype", Circulation, 107, pp.2181~2184 (2003)
- Yang, X., "Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1", 2, 2009, pp.138, 1008~1015
- Alexopoulos, A., "Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves", Int. J. Cardiol, 139, pp.142~149 (2010)
- Filip, D. A., "Cellular events in the development of valvular atherosclerotic lesions induced by experimental hypercholesterolemia", Atherosclerosis, 67, pp.199~214 (1987)
- Syvaranta, S., "Potential pathological roles for oxidized low-density lipoprotein and scavenger receptors SR-AI, CD36, and LOX-1 in aortic valve stenosis", Atherosclerosis, 235, pp.398~407 (2014)
- Meng, X., "Expression of functional Toll-like receptors 2 and 4 in human aortic valve interstitial cells: potential roles in aortic valve inflammation and stenosis", Am. J. Physiol. Cell Physiol, 294, pp.C29~C35 (2008)
- Yang, X., "Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2", J. Am. Coll. Cardiol, 53, pp.491~500 (2009)
- Bischoff, J., "Progenitor cells confer plasticity to cardiac valve endothelium", J. Cardiovasc. Transl. Res, 4, pp.710~719 (2011)
- Olsson, M., "Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves", Arterioscler. Thromb. Vasc. Biol, 19, pp.1218~1222 (1999)
- Mohty, D., "Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis", Arterioscler. Thromb. Vasc. Biol, 28, pp.187~193 (2008)
- O'Brien, K. D., "Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative'valvular aortic stenosis", Arterioscler. Thromb. Vasc. Biol, 16, pp.523~532 (1996)
- Sucosky, P., "Altered shear stress stimulates upregulation of endothelial VCAM-1 and ICAM-1 in a BMP-4- and TGF-beta1-dependent pathway", Arterioscler. Thromb. Vasc. Biol, 29, pp.254~260 (2009)
- Kaden, J. J., "Interleukin-1 beta promotes matrix metalloproteinase expression and cell proliferation in calcific aortic valve stenosis", Atherosclerosis, 170, pp.205~211 (2003)
- Weiss, R. M., "Fibrocalcific aortic valve disease: opportunity to understand disease mechanisms using mouse models", Circ. Res, 113, pp.209~222 (2013)
- Mahler, G. J., "Inflammatory cytokines promote mesenchymal transformation in embryonic and adult valve endothelial cells", Arterioscler. Thromb. Vasc. Biol, 33, pp.121~130 (2013)
- Guerraty, M. A., "Hypercholesterolemia induces side-specific phenotypic changes and peroxisome proliferator-activated receptor-gamma pathway activation in swine aortic valve endothelium", Arterioscler. Thromb. Vasc. Biol, 30, pp.225~231 (2010)
- Duan, S. Z., "Peroxisome proliferator-activated receptor-gamma-mediated effects in the vasculature", Circ. Res, 102, pp.283~294 (2008)
- Jackson, S. M., "Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction", Arterioscler. Thromb. Vasc. Biol, 19, pp.2094~2104 (1999)
- Aikawa, E., "Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease", Circulation, 115, pp.377~386 (2007)
- Otto, C. M., "Characterization of the early lesion of 'degenerative'valvular aortic stenosis. Histological and immunohistochemical studies", Circulation, 90, pp.844~853 (1994)
- Bosse, Y., "Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves", Circ. Cardiovasc. Genet, 2, pp.489~498 (2009)
- Kaden, J. J., "Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification", Int. J. Mol. Med, 16, pp.869~872 (2005)
- Khan, R., "Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia", Immunology, 118, pp.10~24 (2006)
- Parameswaran, N., "Tumor necrosis factor-alpha signaling in macrophages", Crit. Rev. Eukaryot. Gene Expr, 20, pp.87~103 (2010)
- Aikawa, E., "Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease", Circulation, 119, pp.1785~1794 (2009)
- Bobryshev, Y. V., "Monocyte recruitment and foam cell formation in atherosclerosis", Micron, 37, pp.208~222 (2006)
- Brown, M. S., "Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis", Annu. Rev. Biochem, 52, pp.223~261 (1983)
- Choi, J. H., "Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves", J. Exp. Med, 206, pp.497~505 (2009)
- Choi, J. H., "Flt3 signaling-dependent dendritic cells protect against atherosclerosis", Immunity, 35, pp.819~831 (2011)
- Koltsova, E. K., "How dendritic cells shape atherosclerosis", Trends Immunol, 32, pp.540~547 (2011)
- Steiner, I., "Calcific aortic valve stenosis: Immunohistochemical analysis of inflammatory infiltrate", Pathol. Res. Pract, 208, pp.231~234 (2012)
- Wu, H. D., "The lymphocytic infiltration in calcific aortic stenosis predominantly consists of clonally expanded T cells", J. Immunol, 178, pp.5329~5339 (2007)
- Winchester, R., "Circulating activated and effector memory T cells are associated with calcification and clonal expansions in bicuspid and tricuspid valves of calcific aortic stenosis", J. Immunol, 187, pp.1006~1014 (2011)
- Natorska, J., "Presence of B cells within aortic valves in patients with aortic stenosis:Relation to severity of the disease", J. Cardiol, 67, pp.80~85 (2016)
- Han, S. B., "Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus", Int. Immunopharmacol, 3, pp.1301~1312 (2003)
- Mackay, F., "BAFF: a fundamental survival factor for B cells", Nat. Rev. Immunol, 2, pp.465~475 (2002)
- Mackay, F., "BAFF AND APRIL: a tutorial on B cell survival", Annu. Rev. Immunol, 21, pp.231~264 (2003)
- Schneider, P., "BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth", J. Exp. Med, 189, pp.1747~1756 (1999)
- Nardelli, B., "Synthesis and release of B-lymphocyte stimulator from myeloid cells", Blood, 97, pp.198~204 (2001)
- Helske, S., "Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves", Eur. Heart J, 27, pp.1495~1504 (2006)
- Wypasek, E., "Mast cells in human stenotic aortic valves are associated with the severity of stenosis", Inflammation, 36, pp.449~456 (2013)
- Syvaranta, S., "Vascular endothelial growth factor-secreting mast cells and myofibroblasts:a novel self-perpetuating angiogenic pathway in aortic valve stenosis", Arterioscler. Thromb. Vasc. Biol, 30, pp.1220~1227 (2010)
- O'Reilly, M. S., "Endostatin: an endogenous inhibitor of angiogenesis and tumor growth", Cell, 88, pp.277~285 (1997)
- Syvaranta, S., "Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells", Atherosclerosis, 221, pp.366~374 (2012)
